DexCom, Inc. (DXCM)
85.36
-0.87
(-1.01%)
USD |
NASDAQ |
Oct 02, 16:00
85.36
0.00 (0.00%)
After-Hours: 20:00
DexCom Enterprise Value : 31.67B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 31.67B |
| October 01, 2026 | 31.99B |
| September 30, 2026 | 32.02B |
| September 29, 2026 | 32.15B |
| September 28, 2026 | 32.16B |
| September 25, 2026 | 32.14B |
| September 24, 2026 | 32.46B |
| September 23, 2026 | 32.56B |
| September 22, 2026 | 33.24B |
| September 21, 2026 | 33.10B |
| September 18, 2026 | 33.17B |
| September 17, 2026 | 32.64B |
| September 16, 2026 | 32.41B |
| September 15, 2026 | 32.08B |
| September 14, 2026 | 31.41B |
| September 11, 2026 | 30.79B |
| September 10, 2026 | 31.35B |
| September 09, 2026 | 31.11B |
| September 08, 2026 | 31.35B |
| September 04, 2026 | 32.62B |
| September 03, 2026 | 33.31B |
| September 02, 2026 | 33.30B |
| September 01, 2026 | 33.47B |
| August 31, 2026 | 33.82B |
| August 28, 2026 | 33.73B |
| Date | Value |
|---|---|
| August 27, 2026 | 33.15B |
| August 26, 2026 | 33.02B |
| August 25, 2026 | 33.10B |
| August 24, 2026 | 33.82B |
| August 21, 2026 | 34.30B |
| August 20, 2026 | 33.50B |
| August 19, 2026 | 33.37B |
| August 18, 2026 | 33.27B |
| August 17, 2026 | 32.95B |
| August 14, 2026 | 33.32B |
| August 13, 2026 | 33.98B |
| August 12, 2026 | 33.72B |
| August 11, 2026 | 33.24B |
| August 10, 2026 | 32.53B |
| August 07, 2026 | 31.44B |
| August 06, 2026 | 30.78B |
| August 05, 2026 | 30.65B |
| August 04, 2026 | 32.26B |
| August 03, 2026 | 32.40B |
| July 31, 2026 | 30.95B |
| July 30, 2026 | 27.58B |
| July 29, 2026 | 27.81B |
| July 28, 2026 | 27.70B |
| July 27, 2026 | 27.14B |
| July 24, 2026 | 26.45B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 196.37B |
| Insulet Corp. | 9.546B |
| Baxter International, Inc. | 18.82B |
| Stryker Corp. | 117.62B |
| Becton, Dickinson & Co. | 64.10B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 249.10M |
| Revenue (Quarterly) | 1.308B |
| Total Expenses (Quarterly) | 1.059B |
| EPS Diluted (Quarterly) | 0.6429 |
| Gross Profit Margin (Quarterly) | 63.44% |
| Profit Margin (Quarterly) | 19.04% |
| Earnings Yield | 2.97% |
| Operating Earnings Yield | 3.36% |
| Normalized Earnings Yield | 2.968 |